Suchergebnisse - "Strub-Wourgaft, Nathalie"

PubPharm (18)

1

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense : a multicentre, open-label, single-arm, phase 2/3 trial

enthalten in: The Lancet. Infectious diseases | 2023

von Betu Kumeso, V. | Kalonji, W. | Rembry, S. | +28

CommentIn: Lancet Infect Dis. 2023 Apr;23(4):387-388. - PMID 36460028

2

Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis : First-in-Human Study

enthalten in: Clinical pharmacokinetics | 2023

von Tarral, A. | Hovsepian, L. | Duvauchelle, T. | +9

3

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Torrico, F. | Gascón, J. | Ortiz, L. | +11

4

Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program

enthalten in: The American journal of tropical medicine and hygiene | 2022

von Valverde Mordt, O. | Tarral, A. | Strub-Wourgaft, N.

5

Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects

enthalten in: British journal of clinical pharmacology | 2021

von Gillon, J. | Dennison, J. | van den Berg, F. | +10

6

The Chagas disease study landscape : A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform

enthalten in: PLoS neglected tropical diseases | 2021

von Maguire, B. | Dahal, P. | Rashan, S. | +8

7

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA) : a phase 2, double-blind, randomised trial

enthalten in: The Lancet. Infectious diseases | 2021

von Torrico, F. | Gascón, J. | Barreira, F. | +34

CommentIn: Lancet Infect Dis. 2021 Aug;21(8):1057-1058. - PMID 33836159

8

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis : a prospective, multicentre, open-label, cohort study

enthalten in: The Lancet. Global health | 2021

von Kande Betu Ku Mesu, V. | Mutombo Kalonji, W. | Bardonneau, C. | +21

9

Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India

enthalten in: PLoS neglected tropical diseases | 2019

von Goyal, V. | Burza, S. | Pandey, K. | +12

10

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia

enthalten in: PLoS neglected tropical diseases | 2019

von Diro, E. | Blesson, S. | Edwards, T. | +19